Stroke poses a major threat to public health, and this threat is predicted to worsen in the years to come. Simcere is a company dedicated to creating novel therapeutic solutions to meet this urgent ...

After practicing psychiatry for 40 years, I started feeling like I had seen and heard it all. Thousands of patients had come to my office seeking relief from depression, anxiety, and related disorders ...

Bial has introduced a new sublingual formulation of apomorphine in the UK, offering a fresh treatment option for adults with Parkinson’s disease who experience intermittent OFF episodes that are not ...

Please provide your email address to receive an email when new articles are posted on . In pediatric patients, Anaphylm produced a maximum concentration that “slightly exceeded” the one found in ...

Tonmya is the first FDA-approved therapy for the treatment of fibromyalgia in more than 15 years. (HealthDay News) — The U.S. Food and Drug Administration has approved Tonmya (cyclobenzaprine ...

The approval is the first for a fibromyalgia treatment in more than 15 years. It is a first-in-class, nonopioid, once-daily bedtime analgesic. The approval was based on two phase 3 clinical trials of ...

The U.S. Food and Drug Administration has approved Tonmya (cyclobenzaprine hydrochloride) sublingual tablets for the treatment of fibromyalgia in adults. The approval is the first for a fibromyalgia ...

BENGALURU: The Health and Family Welfare Department has written to the Drug Controller General of India (DCGI), seeking an investigation into alleged unethical clinical trials at Bengaluru-based HCG ...

Bengaluru: Amid allegations of unethical clinical trial practices, HealthCare Global Enterprises Limited (HCG), a leading cancer care provider in India, has denied any wrongdoing and reaffirmed its ...

A Prescription Drug User Fee Act target date of January 31, 2026 has been set for the application. The Food and Drug Administration (FDA) has accepted the New Drug Application (NDA) for epinephrine ...